Lung cancer following lung transplant: Single institution 10 year experience

Lung Cancer

Volumn 81, Issue 3, 2013, Pages 451-454

  Belli, E V ^a   Landolfo, K ^a   Keller, C ^a   Thomas, M ^a   Odell, J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Donor lung cancer; Lung; Lung cancer; Post tranplant malignanacy; Psot tranplant neoplasia; Transplantation

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER SURVIVAL; CARCINOID; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT IDENTIFICATION; PERSONAL EXPERIENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMOKING; SOLITARY FIBROUS TUMOR; SQUAMOUS CELL;

DONOR LUNG CANCER; LUNG; LUNG CANCER; POST TRANPLANT MALIGNANACY; PSOT TRANPLANT NEOPLASIA; TRANSPLANTATION;

ADOLESCENT; ADULT; AGED; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LUNG NEOPLASMS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; TISSUE DONORS; TREATMENT OUTCOME; TUMOR BURDEN; YOUNG ADULT;

EID: 84881665601     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2013.05.018     Document Type: Article

References (17)

1. Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1999-2008 2009, U.S. Department of Health and Human Services HRaSA, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD.
2. Hosenpud J.D., Bennett L.E., Keck B.M., Edwards E.B., Novick R.J. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 1998, 351(January (9095)):24-27.
3. Charman S.C., Sharples L.D., McNeil K.D., Wallwork J. Assessment of survival benefit after lung transplantation by patient diagnosis. J Heart Lung Transplant 2002, 21(February (2)):226-232.
4. Eberlein M., Garrity E.R., Orens J.B. Lung allocation in the United States. Clin Chest Med 2011, 32(June (2)):213-222.
5. Gries C.J., Mulligan M.S., Edelman J.D., Raghu G., Curtis J.R., Goss C.H. Lung allocation score for lung transplantation: impact on disease severity and survival. Chest 2007, 132(December (6)):1954-1961.
6. Parada M.T., Sepulveda C., Alba A., Salas A. Malignancy development in lung transplant patients. Transplant Proc 2011, 43(July-August (6)):2316-2317.
7. Amital A., Shitrit D., Raviv Y., Bendayan D., Sahar G., Bakal I., et al. Development of malignancy following lung transplantation. Transplantation 2006, 81(February (4)):547-551.
8. Arcasoy S.M., Hersh C., Christie J.D., Zisman D., Pochettino A., Rosengard B.R., et al. Bronchogenic carcinoma complicating lung transplantation. J Heart Lung Transplant 2001, 20(October (10)):1044-1053.
9. Choi Y.H., Leung A.N., Miro S., Poirier C., Hunt S., Theodore J. Primary bronchogenic carcinoma after heart or lung transplantation: radiologic and clinical findings. J Thorac Imaging 2000, 15(January (1)):36-40.
10. De Perrot M., Waddell T.K., Shargall Y., Pierre A.F., Fadel E., Uy K., et al. Impact of donors aged 60 years or more on outcome after lung transplantation: results of an 11-year single-center experience. J Thorac Cardiovasc Surg 2007, 133(February (2)):525-531.
11. Spiekerkoetter E., Krug N., Hoeper M., Wiebe K., Hamm M., Harringer W., et al. Prevalence of malignancies after lung transplantation. Transplant Proc 1998, 30(June (4)):1523-1524.
12. Adami J., Gäbel H., Lindelöf B., Ekström K., Rydh B., Glimelius B., et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 2003, 89(October (7)):1221-1227.
13. Engels E.A., Pfeiffer R.M., Fraumeni J.F., Kasiske B.L., Israni A.K., Snyder J.J., et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA 2011, 306(November (17)):1891-1901.
14. Dickson R.P., Davis R.D., Rea J.B., Palmer S.M. High frequency of bronchogenic carcinoma after single-lung transplantation. J Heart Lung Transplant 2006, 25(November (11)):1297-1301.
15. Brock M.V., Borja M.C., Ferber L., Orens J.B., Anzcek R.A., Krishnan J., et al. Induction therapy in lung transplantation: a prospective, controlled clinical trial comparing OKT3, anti-thymocyte globulin, and daclizumab. J Heart Lung Transplant 2001, 20(December (12)):1282-1290.
16. Palmer S.M., Miralles A.P., Lawrence C.M., Gaynor J.W., Davis R.D., Tapson V.F. Rabbit antithymocyte globulin decreases acute rejection after lung transplantation: results of a randomized, prospective study. Chest 1999, 116(July (1)):127-133.
17. OPTN/SRTR 2010 Annual Data Report 2010, Department of Health and Human Services HRaSA, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD.